Newsroom

For media inquiries, please contact 340B Health Senior Vice President of Communications Jon Tilton at jon.tilton@340bhealth.org​​​​​​​ or 202-536-2285.

• REPORT: 340B HOSPITALS PROVIDE CARE FOR HIGH PERCENTAGES OF HISTORICALLY UNDERSERVED PATIENTS

  July 29, 2022 in 340B Health News Releases

• 340B HOSPITAL OPERATING MARGINS DROPPED SHARPLY IN FY 2020

  July 20, 2022 in 340B Health News Releases

• BIPARTISAN U.S. HOUSE LETTER CALLS FOR FEDERAL FINES ON DRUG COMPANIES THAT ARE RESTRICTING 340B PRICING

  July 18, 2022 in 340B Health News Releases

• STATEMENT ON BAUSCH HEALTH RESTRICTING 340B DISCOUNTS THROUGH COMMUNITY-BASED PHARMACIES

  July 01, 2022 in 340B Health News Releases

• As Drugmakers Cut Off Discounts, Providers Fret for Low-Income Patients

  July 01, 2022 in 340B in the News

• HRSA DIRECTS UCB TO RESTORE 340B PRICING TO SAFETY-NET HOSPITALS

  June 27, 2022 in 340B Health News Releases

• 340B HOSPITALS REMAIN ON THE FRONT LINES OF THE NATIONAL CAMPAIGN TO PURSUE HEALTH EQUITY

  June 16, 2022 in 340B Health News Releases

• U.S. SUPREME COURT STRIKES DOWN MEDICARE CUTS TO 340B HOSPITALS

  June 15, 2022 in 340B Health News Releases

• 340B HEALTH BOARD ELECTS THREE NEW MEMBERS

  May 25, 2022 in 340B Health News Releases

• FIVE HOSPITAL ASSOCIATIONS URGE APPEALS COURTS TO BACK 340B ENFORCEMENT

  May 17, 2022 in 340B Health News Releases

• FINANCIAL LOSSES FROM DRUG COMPANIES’ 340B RESTRICTIONS HAVE MORE THAN DOUBLED SINCE THE END OF 2021

  May 05, 2022 in 340B Health News Releases

• STATEMENT ON GOVERNMENT APPEAL OF COURT DECISION IN ASTRAZENECA 340B CONTRACT PHARMACY LAWSUIT

  April 13, 2022 in 340B Health News Releases